Brief: Brooklyn Immunotherapeutics Inc- On Sept 9, Co Entered Into A Master Services Agreement With Factor Bioscience Inc.

Ernexa Therapeutics

15/09/2022 21:44

Sept 15 (Reuters) - Brooklyn Immunotherapeutics Inc  BTX.O :
    * BROOKLYN IMMUNOTHERAPEUTICS INC- ON SEPT 9,CO ENTERED INTO
A
MASTER SERVICES AGREEMENT WITH FACTOR BIOSCIENCE INC.,
    * BROOKLYN IMMUNOTHERAPEUTICS- UNDER MSA, FACTOR HAS AGREED
TO
PROVIDE CO WITH MRNA CELL ENGINEERING RESEARCH SUPPORT SERVICES
    * BROOKLYN IMMUNOTHERAPEUTICS INC- COMPANY HAS AGREED TO PAY
FACTOR AN INITIAL FEE OF $5 MILLION

Further company coverage:  BTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))